Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Kala Pharmaceuticals ( (KALA) ).
Mark S. Blumenkranz, M.D. has abruptly resigned from his positions on the Board of Directors, Audit Committee, and Nominating and Corporate Governance Committee of KALA BIO, Inc., effective immediately. His departure is noteworthy for not being linked to any disputes or disagreements with the company’s operations, policies, or practices.
See more data about KALA stock on TipRanks’ Stock Analysis page.